Randomized, comparative study of interferon β-1a treatment regimens in MS
Neurology2002Vol. 59(10), pp. 1496–1506
Citations Over TimeTop 1% of 2002 papers
Hillel Panitch, Douglas S. Goodin, G. Francis, Peter Chang, Patricia K. Coyle, Paul O’Connor, Monaghan Ed, D. Li, Brian G. Weinshenker
Abstract
IFNbeta-1a 44 micro g subcutaneously tiw was more effective than IFNbeta-1a 30 micro g IM qw on all primary and secondary outcomes investigated after 24 and 48 weeks of treatment.
Related Papers
- → A Cross-sectional literature survey showed the reporting quality of multicenter randomized controlled trials should be improved(2021)16 cited
- → Statistical issues relating to international differences in clinical trials(2001)27 cited
- → Single-center versus multicenter trials(1986)13 cited
- → German Multicenter Studies on Plateletpheresis from Healthy Donors(1993)1 cited
- Efficacy and Safety of virtual reality in Stroke Rehabilitation: a multicenter randomized trial (EVREST Multicenter)(2016)